SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-18-008875
Filing Date
2018-04-24
Accepted
2018-04-24 16:05:15
Documents
3
Period of Report
2018-05-29
Effectiveness Date
2018-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A cort-def14a_20180424.htm DEF 14A 804268
2 GRAPHIC g2018042110002496516084.jpg GRAPHIC 73310
3 GRAPHIC g2018042110002493716083.jpg GRAPHIC 83334
  Complete submission text file 0001564590-18-008875.txt   1021305
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50679 | Film No.: 18771486
SIC: 2834 Pharmaceutical Preparations